Director New Business Development Drug Substance
居住城市
Pennsville, New Jersey
功能区域
Business Development & Sales
The Siegfried Group is a global life science company with a network of 13 sites in Europe, the USA, and Asia. Siegfried offers contract development and manufacturing of active pharmaceutical ingredients, intermediates, and drug products and has sales more than CHF 1.3 billion Swiss Franks. Siegfried Holding AG employs over 3,800 people and is listed on the SIX Swiss Exchange (SIX: SFZN).
Purpose of Position
This role is strategically important to our company's mission. You will be key to continuing our remarkable growth story by expanding an already robust & diverse client base of innovator companies. This is an opportunity for an individual to step up to a Director role and join a leader in the growing CDMO industry. Expect to grow here!
在我们公司工作
• Free choice of location paired with remote working
• Flexible working hours
• A generous Employee Stock Purchase Plan
• A generous and stable pension scheme
• Other benefits that tie in with local social security of the location
• We are a growing global company with Swiss roots and 150 years of history
我们是谁
在人们的生活中–全球
齐格菲集团(Siegfried Group)是全球领先的定制开发和制造组织(CDMO)之一,致力于开发和生产活性药物成分(API),中间体和最终剂型。作为我们的核心竞争力,我们成功地将化学和制药能力整合到一个商业模式中。
齐格菲(Siegfried)这个名字代表着最高的质量,效率,灵活性和安全性。我们的业务遍及欧洲,亚洲和北美,从主要的国际制药公司到小型生物制药组织,为广泛的全球客户群提供服务。我们为他们开发和生产大规模的产品创新产品到成品。我们将报价无缝整合到客户的价值链中。我们的综合服务范围涵盖从早期研究与开发服务(例如合成,放大,配方开发,稳定性研究和方法开发)一直到制造服务,从用于临床试验目的的临床前研发材料到商业生产。
我们能够生产约1500种注册药物中的约200种。此外,我们生产的咖啡因占全球需求量的20%。因此,将近10亿个人与Siegfried产品接触。
我们在做什么Pennsville
Pennsville is our drug substance manufacturing site for the US mar-ket and provides spray drying operations globally.
Main activities
- Pilot and commercial manufacturing of drug substances (APIs) and related intermediates
- All fully cGMP and SHE compliant
Features
- 3 GMP pilot suites: 0.1–2 m³ reactors
- 200m3 commercial capacity: 1–10 m³ reactors
- Successful transfer of new products to the commercial scale - Powerful rectification
- Spray drying in pilot and commercial scale for both isolation and dispersion technology
- Micronization in pilot and commercial
Strategic importance
- CMO for innovative drug substances and manufacturer of our opiates portfolio for the US market